Crsp stock forecast 2025.

Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.Oct 26, 2023 · Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...

Nov 17, 2023 · 15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.

Sep 5, 2023 · And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ...

See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.Amazon Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 150.20. Positive dynamics for Amazon shares will prevail with possible volatility of 1.272%. Pessimistic target level: 149.24. Optimistic target level: 151.16.CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...

CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict …

Nov 17, 2023 · 15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.

Nov 21, 2023 · The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence. CRISPR Stock (CRSP) Forecast and Prediction for 2025 In the groundbreaking realm of biotech, few names resonate as strongly as CRISPR Therapeutics. Born out of the …A year ago, CRISPR Therapeutics' (NASDAQ: CRSP) stock was trading for $46 per share. As of Tuesday afternoon, the biotech stock was at $64. It's easy for investors to look at that 39% rise and ...Nokia will start 2025 at $4.39, then soar to $4.44 within the first six months of the year and finish 2025 at $4.50. That means +15% from today. Nokia Stock Forecast 2030-2034. In this period, the Nokia price would rise from $7.31 to $9.18, which is +26%.CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today.

Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...Teladoc Health Inc () Stock Market info Recommendations: Buy or sell Teladoc Health stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Teladoc Health share forecasts, stock quote and buy / sell signals below.According to present data Teladoc Health's TDOC shares and potentially its market environment have …Sep 19, 2023 · 32.69%. Dividend Yield. N/A. More importantly, CRISPR Therapeutics' financial results should improve in the next five years. The company is on the verge of receiving approval for exa-cel, a gene ... 4 ngày trước ... The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 33.8% upside in the stock. While this highly sought-after ...

The average CRISPR Therapeutics AG stock forecast 2024 represents a -25.46% decrease from the last price of $68.6500015258789. For CRISPR Therapeutics AG stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CRISPR Therapeutics AG stock forecast of $49.41, a high forecast of $51.16, and a low forecast of $46.49.

According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst RatingsFind the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing. Assuming $18 billion in free cash flow -- the low end of T-Mobile's target -- and just a 15 P/E ratio in 2025, one could see T-Mobile trading at a market cap of $270 billion, up about 75% from ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below. According to present data AbCellera Biologics's ABCL shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Apr 14, 2022 · The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ... CRISPR Therapeutics AG (CRSP) share price prediction for 2023, 2024, 2025, 2026 and 2027. CRSP one year forecast. CRISPR Therapeutics AG stock monthly and weekly ...Apr 14, 2022 · The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ... According to our CRISPR Therapeutics AG stock prediction for 2025, CRSP stock will be priced at $ 114.05 in 2025. This forecast is based on the stock’s average …Salesforce Inc () Stock Market info Recommendations: Buy or sell Salesforce stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below.According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish …

The market tends to reward companies based on financial results and an improving outlook. Before investing in a stock, intending to hold it long term, it's critical to determine how the company is ...

Dec 1, 2023 · The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors?

Nasdaq Forecast 2023, 2024, 2025. Facebook stock price predictions for March 2024. The forecast for beginning of March 349. Maximum value 377, while minimum 335. Averaged Facebook stock price for month …Find real-time NCLH - Norwegian Cruise Line Holdings Ltd stock quotes, company profile, news and forecasts from CNN Business.CRSP stock soared in 2021 along with many biotech stocks. But there’s been a sharp pullback since then. ... In fact, Pfizer is forecasting that the company’s pipeline will growt by $10 billion ...Jan 13 Show all updates Earnings and Revenue Growth Forecasts Show more Analyst Future Growth Forecasts Earnings vs Savings Rate: CRSP is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CRSP is forecast to remain unprofitable over the next 3 years.That success has led to dramatic price increases for CRSP stock since going public in 2016. Shares flirted with the $200 level in 2021 during the most recent market peak. They currently trade for ...Nov 30, 2023 · Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52. CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price.UBS Stock 12 Months Forecast. $31.25. (19.78% Upside) Based on 13 Wall Street analysts offering 12 month price targets for UBS Group AG in the last 3 months. The average price target is $31.25 with a high forecast of $38.08 and a low forecast of $19.77. The average price target represents a 19.78% change from the last price of $26.09.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ...

AbCellera Biologics Inc () Stock Market info Recommendations: Buy or sell AbCellera Biologics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below.According to present data AbCellera Biologics's ABCL shares and potentially its …Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …Nov 17, 2023 · 15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price. Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …Instagram:https://instagram. how to buy over the counter stockswhich medicaid plan is best in missouritqqq'ben stock dividend Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Dec 1, 2023 · The average twelve-month price prediction for CRISPR Therapeutics is $69.88 with a high price target of $110.00 and a low price target of $42.00. Learn more on CRSP's analyst rating history. Do Wall Street analysts like CRISPR Therapeutics more than its competitors? hlvx stocknyse trading holidays A new market forecast predicts app spending will reach $270 billion by the year 2025, including paid downloads, in-app purchases and subscriptions. According to data from Sensor Tower, in-app spending will return to pre-pandemic levels of s...CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price. gold and silver predictions Target values for the price of one Luminar Technologies share for Mar 2025. The weighted average target price per Luminar Technologies share in Mar 2025 is: 2.61. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.345% volatility is expected. Pessimistic target level: 2.42.Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.Jun 6, 2021 · For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.